Filing Details
- Accession Number:
- 0001384101-24-000170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-29 14:28:47
- Reporting Period:
- 2024-11-27
- Accepted Time:
- 2024-11-29 14:28:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1384101 | Veracyte Inc. | VCYT | Services-Medical Laboratories (8071) | 205455398 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1584145 | Jonathan Wygant | 6000 Shoreline Court, Suite 300 South San Francisco CA 94080 | Vp, Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-27 | 5,032 | $42.89 | 42,313 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Represents weighted average sales price. Sale prices for the transactions range from $42.8028 to $42.9001. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.